Image

Lower Extremity Neuromuscular Assessment in Children with Cerebral Palsy

Lower Extremity Neuromuscular Assessment in Children with Cerebral Palsy

Recruiting
5-16 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to evaluate the reliability (intra-rater and inter-rater) of the K-Pull dynamometer and the K-Myo non-invasive electromyography sensor (assessing neuromuscular activity) in the evaluation of the lower limbs in children with cerebral palsy.

Specific objectives include:

  • Examining differences in neuromuscular activity among children with CP classified at functional levels I to III on the GMFCS scale.
  • Deriving conclusions from the correlation between electromyographic activity, muscle tone, and generated muscle strength.
  • Assessing the applicability of neuromuscular activity assessment devices in clinical settings.

Eligibility

Inclusion Criteria:

  • children with spastic type cerebral palsy (CP),
  • aged between 5 and 16 years,
  • classified at GMFCS levels I to III,
  • voluntary motor control,
  • ambulatory, with or without the use of mobility aids,
  • can understand and execute verbal commands.

Exclusion Criteria:

  • have previously undergone interventions that affect neuromuscular performance (such as surgery or botulinum toxin injections)
  • have sustained an injury,
  • demonstrate a low level of compliance.

Study details
    Force Measurement
    Electromyography
    Children
    Cerebral Palsy
    Lower Limb

NCT06667518

University of Thessaly

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.